Literature DB >> 2318582

Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis.

Y Inoue1, Y Ohashi, Y Shimomura, R Manabe, M Yamada, S Ueda, S Kato.   

Abstract

%$%%protective effect of glycoprotein D (gD) immunization against murine herpetic keratitis was investigated. gD was purified by affinity chromatography using anti-gD monoclonal antibodies. Prior immunization with gD was shown to be effective in protecting mice from both the development of stromal keratitis and the spread of the virus to the central nervous system. The level of serum antibodies for virus neutralization, as well as for complement-dependent cytolysis (CDC), was significantly elevated in gD-immunized animals. Cellular immunity, however, was not detected. These results indicate that two antibody-mediated defense mechanisms--virus neutralization and CDC--were responsible for the protective effect observed in our study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318582

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Detection of cytomegalovirus in urine samples by an enzyme-linked immunosorbent assay using a monoclonal antibody against the viral 150-kilodalton protein.

Authors:  T Yamanaka; K Kiyotani; T Sakaguchi; Y Fukuda; K Dohi; M Yamada; M Yoshida; S Nii; T Yoshida
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.

Authors:  Y F Yao; Y Inoue; T Kase; Y Uchihori; Y Mori; Y Ohashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Is vision metric? Comment on Lappin and Love (1992).

Authors:  Z Pizlo; M Salach-Golyska
Journal:  Percept Psychophys       Date:  1994-02

4.  Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.

Authors:  A Thakur; J Kyd; M Xue; M D Willcox; A Cripps
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Utilization of complement-dependent cytotoxicity to measure low levels of antibodies: application to nonstructural protein 1 in a model of Japanese encephalitis virus.

Authors:  Eiji Konishi; Yoko Kitai; Takashi Kondo
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

6.  Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2.

Authors:  Tomomi Morimoto; Jun Arii; Michiko Tanaka; Tetsutaro Sata; Hiroomi Akashi; Masao Yamada; Yukihiro Nishiyama; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

7.  Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo.

Authors:  H Aoki; T Akaike; K Abe; M Kuroda; S Arai; R Okamura; A Negi; H Maeda
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

Review 8.  Recurrent herpetic stromal keratitis in mice: a model for studying human HSK.

Authors:  Patrick M Stuart; Tammie L Keadle
Journal:  Clin Dev Immunol       Date:  2012-04-23

Review 9.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.